Different Oral Cancer Scenarios to Personalize Targeted Therapy: Boron Neutron Capture Therapy Translational Studies

References

• Rivera C . Essentials of oral cancer. Int. J. Clin. Exp. Pathol.8(9), 11884–11894 (2015).
   PubMed Web of Science ®Google Scholar
• Islam S , AbikoY , UeharaO , ChibaI. Sirtuin 1 and oral cancer. Oncol. Lett.17(1), 729–738 (2019).
   PubMed Web of Science ®Google Scholar
• Kumar M , NanavatiR , ModiTG , DobariyaC. Oral cancer: etiology and risk factors: a review. J. Cancer. Res. Ther.12(2), 458–463 (2016).
   PubMed Web of Science ®Google Scholar
• Andreassen CN , EriksenJG , JensenKet al. IMRT – biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncol.86, 91–99 (2018).
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ , TaborMP , KummerJA , LeemansCR , BrakenhoffRH. A genetic explanation of slaughter’s concept of field cancerization: evidence and clinical implications. Cancer Res.63(8), 1727–1730 (2003).
   PubMed Web of Science ®Google Scholar
• Jaiswal G , JaiswalS , KumarR , SharmaA. Field cancerization: concept and clinical implications in head and neck squamous cell carcinoma. J. Exp. Ther. Oncol.10, 209–214 (2013).
   PubMedGoogle Scholar
• Monti-Hughes A , AromandoRF , PérezMA , SchwintAE , ItoizME. The hamster cheek pouch model for field cancerization studies. Periodontol. 200067(1), 292–311 (2015a).
   PubMed Web of Science ®Google Scholar
• Li CC , ShenZ , BavarianR , YangF , BhattacharyaA. Oral cancer: genetics and the role of precision medicine. Dent. Clin. North. Am.62(1), 29–46 (2018).
   PubMedGoogle Scholar
• Ford PJ , FarahCS. Early detection and diagnosis of oral cancer: strategies for improvement. J. Cancer Policy1, e2–e7 (2013).
   Google Scholar
• Chung CM , LeeCH , ChenMKet al. Combined genetic biomarkers and betel quid chewing for identifying high-risk group for oral cancer occurrence. Cancer Prev. Res. (Phila)10(6), 355–362 (2017).
   PubMed Web of Science ®Google Scholar
• Rimal J , ShresthaA , MaharjanIK , ShresthaS , ShahP. Risk assessment of smokeless tobacco among oral precancer and cancer patients in eastern developmental region of Nepal. Asian Pac. J. Cancer Prev.20(2), 411–415 (2019).
   PubMedGoogle Scholar
• Jensen SB , PetersonDE. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. J. Oral Pathol. Med.43(2), 81–90 (2014).
   PubMed Web of Science ®Google Scholar
• Cinausero M , AprileG , ErmacoraPet al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front. Pharmacol.8, 354 (2017).
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A , MoslemiD , AkbariJet al. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study. Clin. Oral Investig.22(6), 2263–2272 (2018).
   PubMed Web of Science ®Google Scholar
• Mallick S , BensonR , RathGK. Radiation induced oral mucositis: a review of current literature on prevention and management. Eur. Arch. Otorhinolaryngol.273(9), 2285–2293 (2016).
   PubMed Web of Science ®Google Scholar
• Sangild PT , ShenRL , PontoppidanP , RatheM. Animal models of chemotherapy-induced mucositis: translational relevance and challenges. Am. J. Physiol. Gastrointest. Liver Physiol.314(2), G231–G246 (2018).
   PubMed Web of Science ®Google Scholar
• Villa A , SonisST. Mucositis: pathobiology and management. Curr. Opin. Oncol.27(3), 159–64 (2015).
   PubMed Web of Science ®Google Scholar
• Kankaanranta L , SeppäläT , KoivunoroHet al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a Phase I/II trial. Int. J. Radiat. Oncol. Biol. Phys.82(1), e67–e75 (2012).
   PubMedGoogle Scholar
• Lim D , QuahDS , LeechM , MarignolL. Clinical potential of boron neutron capture therapy for locally recurrent inoperable previously irradiated head and neck cancer. Appl. Radiat. Isot.106, 237–241 (2015).
   PubMed Web of Science ®Google Scholar
• Schwint AE , TrivillinVA. ‘Close-to-ideal’ tumor boron targeting for boron neutron capture therapy is possible with ‘less-than-ideal’ boron carriers approved for use in humans. Ther. Deliv.6(3), 269–272 (2015).
   PubMedGoogle Scholar
• Barth RF , ZhangZ , LiuT. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Commun.38(1), 36 (2018).
   Web of Science ®Google Scholar
• Farhood B , SamadianH , GhorbaniM , ZakariaeeSS , KnaupC. Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy. Rep. Pract. Oncol. Radiother.23(5), 462–473 (2018).
   PubMedGoogle Scholar
• Trivillin VA , HeberEM , NiggDWet al. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically nonselective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat. Res.166(2), 387–396 (2006).
   PubMed Web of Science ®Google Scholar
• Monti Hughes A , PozziEC , ThorpSet al. Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model. Oral Dis.19(8), 789–795 (2013).
   PubMed Web of Science ®Google Scholar
• Menéndez PR , RothBM , PereiraMDet al. BNCT for skin melanoma in extremities: updated Argentine clinical results. Appl. Radiat. Isot.67(7-8 Suppl), S50–53 (2009).
   PubMed Web of Science ®Google Scholar
• Hiratsuka J , KamitaniN , TanakaRet al. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses. Cancer Commun.38(1), 38 (2018).
   Google Scholar
• Wang LW , LiuYH , ChouFI , JiangSH. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor. Cancer Commun.38(1), 37 (2018).
   Web of Science ®Google Scholar
• Kikuchi S , KanohD , SatoS , SakuraiY , SuzukiM , NakamuraH. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy. J. Control. Rel.237, 160–167 (2016).
   PubMed Web of Science ®Google Scholar
• Fuentes I , García-MendiolaT , SatoSet al. Metallacarboranes on the road to anticancer therapies: cellular uptake, DNA interaction, and biological evaluation of cobaltabisdicarbollide [COSAN]. Chemistry24(65), 17239–17254 (2018).
   PubMed Web of Science ®Google Scholar
• Teixidor F , SillanpääR , PepiolA , LupuM , ViñasC. Synthesis of globular precursors. Chemistry 121(36), 12778–12786 (2015).
   PubMed Web of Science ®Google Scholar
• Barth RF , MiP , YangW. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun.838, 35 (2018).
   Google Scholar
• Barth RF . From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy. Appl. Radiat. Isot.106, 22–28 (2015).
   PubMed Web of Science ®Google Scholar
• Workman P , AboagyeEO , BalkwillFet al. Committee of the National Cancer Research Institute (2010) Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer.102(11), 1555–1577 (2010).
   PubMed Web of Science ®Google Scholar
• Sonis ST , PetersonRL , EdwardsLJet al. Defining mechanisms of action of interleukin-11 on the progression of radiation induced oral mucositis in hamsters. Oral Oncol.36, 373–381 (2000).
   PubMed Web of Science ®Google Scholar
• López Castaño F , Oñate-SánchezRE , Roldán-ChicanoR , Cabrerizo-MerinoMC. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Med. Oral Patol. Oral Cir. Bucal10, 412–421 (2005).
   PubMedGoogle Scholar
• Patil S , RaoR , RajT. Animal models – decoding the molecular biology of oral cancer. J. Contemp. Dent. Pract.16(4), i–ii (2015).
   Google Scholar
• El-Bayoumy K , ChenKM , ZhangSMet al. Carcinogenesis of the oral cavity: environmental causes and potential prevention by black raspberry. Chem. Res. Toxicol.30(1), 126–144 (2017).
   PubMed Web of Science ®Google Scholar
• Nagini S , KowshikJ. The hamster buccal pouch model of oral carcinogenesis. Methods Mol. Biol.1422, 341–350 (2016).
   PubMedGoogle Scholar
• Kreimann EL , ItoizME , LonghinoJ , BlaumannH , CalzettaO , SchwintAE. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res.61, 8638–8642 (2001).
   PubMed Web of Science ®Google Scholar
• Kato I , OnoK , SakuraiYet al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl. Radiat. Isot.61(5), 1069–1073 (2004).
   PubMed Web of Science ®Google Scholar
• Heber EM , HawthorneMF , KuefferPJet al. Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model. Proc. Natl Acad. Sci. USA111(45), 16077–16081 (2014).
   PubMed Web of Science ®Google Scholar
• Heber EM , MontiHughes A , PozziECet al. Development of a model of tissue with potentially malignant disorders (PMD) in the hamster cheek pouch to explore the long-term potential therapeutic and/or toxic effects of different therapeutic modalities. Arch. Oral Biol.55(1), 46–51 (2010).
   PubMed Web of Science ®Google Scholar
• Monti Hughes A , PozziEC , HeberEMet al. Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval. Oral Oncol.47, 1017–1022 (2011).
   PubMed Web of Science ®Google Scholar
• González SJ , PozziECC , MontiHughes Aet al. Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer. Phys. Med. Biol.62(20), 7938–7958 (2017).
   PubMed Web of Science ®Google Scholar
• Monti Hughes A , PozziE , ThorpSIet al. Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model. Oral Dis.21(6), 770–777 (2015b).
   PubMed Web of Science ®Google Scholar
• Medina VA , RiveraES. Histamine receptors and cancer pharmacology. Br. J. Pharmacol.161(4), 755–767 (2010).
   PubMed Web of Science ®Google Scholar
• Monti Hughes A , LonghinoJ , BoggioEet al. Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new “B2” configuration of the RA-6 nuclear reactor. Radiat. Environ. Biophys.56(4), 377–387 (2017).
   PubMed Web of Science ®Google Scholar
• Detta A , CruickshankGS. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res.69(5), 2126–2132 (2009).
   PubMed Web of Science ®Google Scholar
• Yoshimoto M , KuriharaH , HondaNet al. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells. Nucl. Med. Biol.40(5), 625–629 (2013).
   PubMed Web of Science ®Google Scholar
• Baskar R , DaiJ , WenlongN , YeoR , YeohKW. Biological response of cancer cells to radiation treatment. Front. Mol. Biosci.1(24), 1–9 (2014).
   PubMedGoogle Scholar
• Tani H , KuriharaH , HiroiKet al. Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers. Radiother. Oncol.113(2), 193–197 (2014).
   PubMed Web of Science ®Google Scholar
• Kobayashi K , KuriharaH , WatanabeYet al. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer. Appl. Radiat. Isot.115, 138–146 (2016).
   PubMed Web of Science ®Google Scholar